Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
There has been ongoing debate regarding the precise identity of the AT4 receptor, with some evidence suggesting it is the insulin-regulated aminopeptidase (IRAP)
Importantly, BPC157 did not have any anti-cancer effects as evidenced by resecting xenograft tumors, which did not show any difference in tumor volumes or food intake between the groups
The early growth response gene (egr-1) activation observed with BPC-157 treatment may be particularly relevant in diabetic healing
A 2023 pharmaceutical review cautioned that BPC-157 increases VEGFR2 expression and that VEGF pathways are active in many human cancers
US$ 25.14
US$ 25.30
US$ 20.43
US$ 22.30
US$ 24.59
US$ 24.50
US$ 23.34
US$ 29.25
